Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Hepatitis C treatment may cause frontal fibrosing alopecia.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Recognizing specific features of African-American hair can help diagnose hair loss conditions.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

Early and accurate diagnosis of posterior scalp hair loss is crucial for effective treatment and better outcomes.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.